EGFR and neoplasm: Epidermal growth factor receptor (EGFR), an essential therapeutic target in the anticancer pathway, is associated with tumor cell proliferation, differentiation, apoptosis, and angiogenesis (Ayati et al., 2020; Zhang et al., 2018).